Dr. Bollyky is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000Fax+1 650-736-5299
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 2013 - 2015
Brigham and Women's HospitalResidency, Internal Medicine, 2001 - 2004
David Geffen School of Medicine at UCLAClass of 2000
Certifications & Licensure
CA State Medical License 2013 - 2024
WA State Medical License 2004 - 2013
MA State Medical License 2002 - 2005- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 248 citationsRapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell FunctionS. Alice Long, Mary Rieck, Srinath Sanda, Jennifer B. Bollyky, Peter L. Samuels
Diabetes. 2012-09-01 - 189 citations4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancerNadine Nagy, Hedwich F. Kuipers, Adam Frymoyer, Heather D. Ishak, Jennifer B. Bollyky
Frontiers in Immunology. 2015-03-23 - 32 citationsThe pharmacokinetics and dosing of oral 4-methylumbelliferone for inhibition of hyaluronan synthesis in mice.Hedwich F. Kuipers, Nadine Nagy, Shannon M. Ruppert, Vivekananda Gupta Sunkari, Payton L. Marshall
Clinical and Experimental Immunology. 2016-09-01
Press Mentions
COVID-19 Vaccines for Kids: What You Need to KnowSeptember 21st, 2021
New Study Reveals Personalization Is Key to Diabetes ManagementOctober 2nd, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
